Complix's Series A Round

Complix raised a round of funding on June 03, 2010.

Complix is a biopharmaceutical company developing a pipeline of transformative protein therapeutics, called Alphabodies, that mainly focus on oncology and autoimmune diseases. Alphabodies are a class …

Articles about Complix's Series A Round: